Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis
- PMID: 9566468
- DOI: 10.1177/0272989X98018002S09
Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis
Abstract
In recent years, considerable attention has been devoted to the development of statistical methods for the analysis of uncertainty in cost-effectiveness (CE) analysis, with a focus on situations in which the analyst has patient-level data on the costs and health effects of alternative interventions. To date, discussions have focused almost exclusively on addressing the practical challenges involved in estimating confidence intervals for CE ratios. However, the general approach of using confidence intervals to convey information about uncertainty around CE ratio estimates suffers from theoretical limitations that render it inappropriate in many situations. The authors present an alternative framework for analyzing uncertainty in the economic evaluation of health interventions (the "net health benefits" approach) that is more broadly applicable and that avoids some problems of prior methods. This approach offers several practical and theoretical advantages over the analysis of CE ratios, is straightforward to apply, and highlights some important principles in the theoretical underpinnings of CE analysis.
Comment in
-
Uncertainty in decision models analyzing cost-effectiveness.Med Decis Making. 2000 Jan-Mar;20(1):135-7. doi: 10.1177/0272989X0002000118. Med Decis Making. 2000. PMID: 10638547 No abstract available.
Similar articles
-
Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.Health Econ. 1996 Jul-Aug;5(4):297-305. doi: 10.1002/(SICI)1099-1050(199607)5:4<297::AID-HEC216>3.0.CO;2-T. Health Econ. 1996. PMID: 8880166
-
Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.Health Econ. 1997 Jul-Aug;6(4):327-40. doi: 10.1002/(sici)1099-1050(199707)6:4<327::aid-hec282>3.0.co;2-w. Health Econ. 1997. PMID: 9285227 Review.
-
Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies.Pharmacoeconomics. 2003;21(1):39-48. doi: 10.2165/00019053-200321010-00003. Pharmacoeconomics. 2003. PMID: 12484802 Review.
-
Stochastic league tables: an application to diabetes interventions in the Netherlands.Health Econ. 2005 May;14(5):445-55. doi: 10.1002/hec.945. Health Econ. 2005. PMID: 15386648
-
A note on confidence intervals in cost-effectiveness analysis.Int J Technol Assess Health Care. 1998 Summer;14(3):467-71. doi: 10.1017/s0266462300011442. Int J Technol Assess Health Care. 1998. PMID: 9780533
Cited by
-
Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients.PLoS One. 2016 Apr 28;11(4):e0154386. doi: 10.1371/journal.pone.0154386. eCollection 2016. PLoS One. 2016. PMID: 27124410 Free PMC article. Clinical Trial.
-
Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysis.BMC Med Res Methodol. 2012 Jan 10;12:3. doi: 10.1186/1471-2288-12-3. BMC Med Res Methodol. 2012. PMID: 22233221 Free PMC article.
-
Optimal global value of information trials: better aligning manufacturer and decision maker interests and enabling feasible risk sharing.Pharmacoeconomics. 2013 May;31(5):393-401. doi: 10.1007/s40273-013-0038-5. Pharmacoeconomics. 2013. PMID: 23529209 Review.
-
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.Psychiatr Serv. 2016 Oct 1;67(10):1124-1130. doi: 10.1176/appi.ps.201500447. Epub 2016 Jun 1. Psychiatr Serv. 2016. PMID: 27247177 Free PMC article. Clinical Trial.
-
Pembrolizumab vs cemiplimab for the treatment of advanced non-small cell lung cancer with PD-L1 expression levels of at least 50%: A network meta-analysis and cost-effectiveness analysis.Front Oncol. 2022 Sep 26;12:878054. doi: 10.3389/fonc.2022.878054. eCollection 2022. Front Oncol. 2022. PMID: 36226060 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical